21 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... own benefits and risks ... the hypoglycemia risk ... pharmacotherapy #table ... #endocrinology
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Type 2 Diabetes ... and Management Algorithm ... • Secondary Causes ... Targets #Management #algorithm ... #DM2 #DMII #Classification
Hyperglycemia - Differential Diagnosis Algorithm
Diabetes Mellitus:
 • Impaired Glucose Tolerance
 • Type I Diabetes
 • Type
Differential Diagnosis Algorithm ... Diabetes Mellitus ... Differential #Diagnosis #Algorithm ... #endocrinology ... #causes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... insulin in Type 1 Diabetes ... pharmacology #comparison #table ... #endocrinology
A priority in this project was to appropriately stratify participants into a low, medium, or high-intensity
group-based exercise class ... The classification ... for Fall Risk Assessment ... The algorithm is ... #Fall #Risk #Screening
Amenorrhea - Differential Diagnosis Algorithm
Elevated FSH
 • Premature Ovarian Failure
 • Menopa use
 • Spontaneous
Bleed With
Differential Diagnosis Algorithm ... Hyperthyroidism • Diabetes ... Differential #Diagnosis #Algorithm ... #endocrinology ... #causes
Hypomagnesemia - Etiologies by Mechanism

Decreased GI Uptake 
 - Poor dietary intake (particularly common in alcoholics)
Excessive GI losses ... - Uncontrolled diabetes ... Low #Magnesium #Table ... #Classification ... #Causes #Workup
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Ozempic), or daily tablet ... outcomes in high risk ... effect) • May ↑ risk ... #Summary #DM2 #diabetes ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
Januvia) - Once/day tablet ... Onglyza) - Once/day tablet ... associated with t risk ... #Summary #DM2 #diabetes ... #endocrinology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
metabolic equivalent able ... ASA class If ... event, follow ACC algorithm ... Stable patients ... Diabetes regimen